Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Guida

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Clinical Genitourinary Cancer|July 23, 2020
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation StudyFrancesco Massari, Vincenzo Di Nunno, Annalisa Guida, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
BMC Cancer|February 15, 2022
Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot studyMaria Letizia Calandrella, Simona Francesconi, Cecilia Caprera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2017
Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centreMargarida Matias, Gwénaël Le Teuff, Laurence Albiges, et al.
Future Oncology (London, England)|November 7, 2015
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysisAnnalisa Guida, Cristina Masini, Michele Milella, et al.
Journal of Clinical Medicine|May 14, 2025
Fast-Track Diagnostic Pathway for Lung Cancer Detection: Single-Center ExperienceValentina Tassi, Roland Peraj, Daina Pietraforte, et al.
Clinical Genitourinary Cancer|October 24, 2021
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell CarcinomaLuigi Cerbone, Vincenzo Di Nunno, Lucia Carril Ajuria, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 4, 2022
Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti-PD-1 therapySara De Biasi, Annalisa Guida, Domenico Lo Tartaro, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 29, 2022
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinomaEmeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical Genitourinary Cancer|July 23, 2020
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation StudyFrancesco Massari, Vincenzo Di Nunno, Annalisa Guida, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
BMC Cancer|February 15, 2022
Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot studyMaria Letizia Calandrella, Simona Francesconi, Cecilia Caprera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2017
Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centreMargarida Matias, Gwénaël Le Teuff, Laurence Albiges, et al.
Future Oncology (London, England)|November 7, 2015
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysisAnnalisa Guida, Cristina Masini, Michele Milella, et al.
Journal of Clinical Medicine|May 14, 2025
Fast-Track Diagnostic Pathway for Lung Cancer Detection: Single-Center ExperienceValentina Tassi, Roland Peraj, Daina Pietraforte, et al.
Clinical Genitourinary Cancer|October 24, 2021
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell CarcinomaLuigi Cerbone, Vincenzo Di Nunno, Lucia Carril Ajuria, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 4, 2022
Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti-PD-1 therapySara De Biasi, Annalisa Guida, Domenico Lo Tartaro, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 29, 2022
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinomaEmeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
Pageof 5